关于重症COVID-19患者住院死亡风险因素的病例控制研究
Kemei Wu1,2, Lili Yin2, Jiangqin Han1,2
1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
晚年,呼吸不全和白细胞 (WBC) 和肌酸酶 (CK) 水平升高是严重的COVID-19患者死亡的关键风险因素. 这些因素,以及动脉氧气部分压力 (PAO2) 的降低,预测了医院死亡风险.
科学领域:
- 传染性疾病 传染性疾病
- 临界护理医学 临界护理医学
- 流行病学 流行病学
背景情况:
- 2019年严重的冠状病毒病 (COVID-19) 对患者的生存构成重大威胁.
- 确定严重结果的独立风险因素和预测因素对于有效的患者管理至关重要.
研究的目的:
- 确定与严重COVID-19患者死亡率相关的独立风险因素.
- 探索表明COVID-19病例严重性的预测因素.
主要方法:
- 一项回顾性,观察性,病例控制性研究对患有严重COVID-19的成年患者进行.
- 用单变量和多因素逻辑回归分析来检查人口统计,并发病和实验室参数.
主要成果:
- 与幸存者相比,已故的患者年龄较大,呼吸不全的发病率较高.
- 升高的白细胞 (WBC) 计数和肌酸酶 (CK) 水平,以及降低动脉氧部分压力 (PAO2) 与死亡率有显著的相关性.
- 对死亡率的预测值 (AUC) 被确定为年龄,呼吸不全,最高WBC,最高CK和第一个PAO2值.
结论:
- 晚年,呼吸不全,WBC和CK升高,PAO2降低是严重COVID-19死亡的重要风险因素.
- 升高的WBC和CK水平显示出医院死亡风险的强有力的预测价值.
更多相关视频
07:16An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
相关概念视频
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Coronary Syndrome IV: Interprofessional Care
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-III
